Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor

Journal of Peptide Science

Volumn 12, Issue 8, 2006, Pages 515-524

  Fletcher, Jordan M ^a   Hughes, Richard A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Agonist; Antagonist; BDNF; Cyclic; Dimeric; Disulphide; Neurotrophic factor; Neurotrophin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PEPTIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHICKEN; CONTROLLED STUDY; DIMERIZATION; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE CELL; SPINAL GANGLION;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; ANIMALS; BIOMIMETICS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; DIMERIZATION; GANGLIA, SPINAL; MODELS, CHEMICAL; MODELS, MOLECULAR; NEURONS, AFFERENT; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY;

EID: 33747251548     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.760     Document Type: Article

References (40)

1. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu. Rev. Neurosci. 1996; 19: 289-317.
2. Thoenen H. Neurotrophins and activity-dependent plasticity. Prog. Brain Res. 2000; 128: 183-191.
3. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 1994; 25: 1418-1435.
4. Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992; 360: 753-755.
5. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992: 360: 757-759.
6. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004; 27: 723-749.
7. Mizuno K, Carnahan J, Nawa H. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev. Biol. 1994; 165: 243-256.
8. Feigin A, Zgaljardic D. Recent advances in Huntington's disease: implications for experimental therapeutics. Curr. Opin. Neurol. 2002; 15: 483-489.
9. Alderson RF, Alterman AL, Barde YA, Lindsay RM. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990; 5: 297-306.
10. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237-1239.
11. Levivier M, Przedborski S, Bencsics C, Kang UJ. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 1995; 15: 7810-7820.
12. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
13. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J. Clin. Oncol. 1999; 17: 2264-2279.
14. Montano X, Djamgoz MB. Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. FEBS Lett. 2004; 571: 1-8.
15. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 2003; 72: 609-642.
16. Barbacid M. Structural and functional properties of the TRK family of neurotrophin receptors. Ann. N. Y. Acad. Sci. 1995; 766: 442-458.
17. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 1988; 57: 443-478.
18. Jing S, Tapley P, Barbacid M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 1992; 9: 1067-1079.
19. Rodriguez-Tebar A, Dechant G, Barde YA. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 1990; 4: 487-492.
20. Liepinsh E, Ilag LL, Otting G, Ibanez CF. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 1997; 16: 4999-5005.
21. Coulson EJ, Reid K, Baca M, Shipham KA, Hulett SM, Kilpatrick TJ, Bartlett PF. Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J. Biol. Chem. 2000; 275: 30537-30545.
22. Bibel M, Hoppe E, Barde YA. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 1999; 18: 616-622.
23. Gentry JJ, Barker PA, Carter BD. The p75 neurotrophin receptor: multiple interactors and numerous functions. Prog. Brain Res. 2004; 146: 25-39.
24. McDonald NQ, Lapatto R, Murray-Rust J, Gunning J, Wlodawer A, Blundell TL. New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature 1991; 354: 411-414.
25. Butte MJ, Hwang PK, Mobley WC, Fletterick RJ. Crystal structure of neurotrophin-3 homodimer shows distinct regions are used to bind its receptors. Biochemistry 1998; 37: 16846-16852.
26. Robinson RC, Radziejewski C, Spraggon G, Greenwald J, Kostura MR, Burtnick LD, Stuart DI, Choe S, Jones EY. The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/ neurotrophin 4 heterodimer reveal a common Trk-binding site. Protein Sci. 1999; 8: 2589-2597.
27. Ibanez CF. Neurotrophic factors: from structure-function studies to designing effective therapeutics. Trends Biotechnol. 1995; 13: 217-227.
28. Wiesmann C, Ultsch MH, Bass SH, de Vos AM. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999; 401: 184-188.
29. O'Leary PD, Hughes RA. Structure-activity relationships of conformationally constrained peptide analogues of loop 2 of brain-derived neurotrophic factor. J. Neurochem. 1998; 70: 1712-1721.
30. O'Leary PD, Hughes RA. Design of potent peptide mimetics of brain-derived neurotrophic factor. J. Biol. Chem. 2003; 278: 25738-25744.
31. The BDNF Study Group (phase III). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.
32. Thoenen H, Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 2002; 5: 1046-1050.
33. Mitsumoto H, Gordon P, Kaufmann P, Gooch CL, Przedborski S, Rowland LP. Randomized control trials in ALS: lessons learned. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2004; 5: 8-13.
34. Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res. Mol. Brain Res. 1996; 36: 280-286.
35. Pardridge WM, Kang YS, Buciak JL. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 1994; 11: 738-746.
36. Fields GB, Noble RL. Solid-phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990; 35: 161-214.
37. Tam JP, Wu CR, Liu W, Zhang JW. Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J. Am. Chem. Soc. 1991; 113: 6657-6662.
38. Kamber B, Hartmann A, Eisler K. et al. The synthesis of cystine peptides by iodine oxidation of S-tritylcysteine and S-acetamidomethylcysteine peptides. Helv. Chim. Acta 1980; 63: 899-915.
39. Fletcher JM, Hughes RA. A novel approach to the regioselective synthesis of a disulfide-linked heterodimeric bicyclic peptide mimetic of brain-derived neurotrophic factor. Tetrahedron Lett. 2004; 45: 6999-7001.
40. Windisch JM, Marksteiner R, Lang ME, Auer B, Schneider R. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 bind to a single leucine-rich motif of TrkB. Biochemistry 1995; 34: 11256-11263.